Amarin Corp Plc (AMRN)

[BostonTrader]

My concern from an investor standpoint is the FDA, plain and simple. With them as I have seen in other biotechs, you just never know until the approval comes. Most of what I have read puts Vascepa in a good position to get the expanded label, but I am not a medical guy, so I hope I am not missing something.

From a trading point, too many people are playing the options and getting burned. The returns are great when you hit, but the real
manipulation always starts in the options.